News|Videos|June 19, 2024
Strategies for Discussing Potential Adverse Effects of Talquetamab in MM
Experts discuss best practices for educating patients with multiple myeloma on the adverse effects associated with talquetamab treatment.
Advertisement
Episodes in this series
Advertisement
Related to this article
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Anktiva Plus BCG: Telling Expected Immune Effects From Red Flags
2
Automated Breast Ultrasound Tied to Fewer False-Positives in Dense Breasts
3
Future Directions in Metastatic Triple-Negative Breast Cancer Care
4
FDA Expands Anktiva Approval to Papillary-Only BCG-Unresponsive NMIBC
5